Witfire Elite  ·  Contact
Four doors. Pick the one that matches what you are actually sending.

Witfire Elite publishes pharma, biotech, healthcare, medical technology, CRO, diagnostic, hospital and life-science business analysis for a professional audience. Everything below reaches the editor directly.

01  ·  Routes

Where to send what

1

You have a decision in front of you

A facility you inherited and never audited. A target you are evaluating. A filing you are preparing. A comparison you cannot verify. This is commissioned work, and it is private.
Go to
2

You have news to submit

Funding, launches, partnerships, regulatory milestones, appointments. Send the primary document — the release, the filing, the approval letter — not a summary of it. Coverage is never guaranteed and never sold.
Go to
Form below
Attach the source document
3

You have found an error

A figure that does not match the filing, a date that is wrong, a source we misread. Corrections are made openly and dated, not quietly edited. Tell us which brief and which line.
Go to
Form below
See Corrections Policy
4

You want to advertise or sponsor

Sponsored placement and commissioned editorial are available. Both are labelled on the page, every time. Editorial coverage is not for sale in any format.
Go to
Form below
See Advertising Policy
02  ·  Coverage

What we cover, and what we accept

Desks
  • FDA & regulatory intelligence
  • CMC & manufacturing risk
  • Clinical catalysts and readouts
  • Capital, deals and stock market
  • Investor risk and due diligence
  • India pharma and export policy
  • Accepted submissions
  • Company announcements and funding news
  • Regulatory milestones and approvals
  • Product launches and partnerships
  • Founder and executive features
  • Selected sponsored articles
  • Corrections and source challenges
  • Before you send

    Sponsored and commissioned material is labelled as such on the page, every time, without exception. Editorial coverage is never sold. If a submission cannot carry that label honestly, we are not the right home for it.

    Every figure published here traces to a primary source. If your release contains a number that does not appear in a filing, a dataset or a publication, expect to be asked where it came from — and expect it to be left out if the answer is not available.

    Read the Editorial Policy, Corrections Policy and Advertising Policy before submitting.

    03  ·  Commissioned work

    If it is a decision rather than an announcement

    Commissioned Analysis
    The same method, applied privately to your own file.

    CMC and manufacturing risk assessment, CRL readiness review, due diligence on a target or partner, investor briefs and commissioned editorial. Delivered by the research team that writes every brief on this site.

    Facility check
    from $800
    Turnaround
    3 days – 4 weeks
    Scope call
    Free
    See what can be commissioned →
    04  ·  Send it

    One form, all four routes

    Start here
    Tell us which door you are using.

    Select the route in the form below and describe what you are sending in a single paragraph. For commissioned work, the most useful first message is what you are deciding and by when — everything else can be worked out on the call.

    Replies come from the editor, usually within two working days. Nothing you send is published, quoted or forwarded. Enquiries are treated as confidential whether or not anything follows.
    Witfire / Commissioned Analysis

    Put this framework on your own file.

    The same method used in these briefs, applied privately to a decision you are actually facing — a target, a partner, a facility, a filing.

    • CMC & manufacturing risk assessment
    • Regulatory / CRL readiness review
    • Due diligence on a target or partner
    • Investor brief or market analysis
    • Commissioned editorial
    • Something else

    Replies come from the editor, usually within two working days. Nothing you send is published.